The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers
1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma...
Gespeichert in:
Veröffentlicht in: | British journal of clinical pharmacology 1994-01, Vol.37 (1), p.21-25 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 25 |
---|---|
container_issue | 1 |
container_start_page | 21 |
container_title | British journal of clinical pharmacology |
container_volume | 37 |
creator | Walle, UK Fagan, TC Topmiller, MJ Conradi, EC Walle, T |
description | 1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P < 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P < 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P < 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P < 0.001). |
doi_str_mv | 10.1111/j.1365-2125.1994.tb04233.x |
format | Article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1364704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BCP4233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</originalsourceid><addsrcrecordid>eNqVkFuL1DAUx4Mo67j6EYQgvrbm5NbWB0WH9QIL-rA-hzRJZzK0SUm6OvvtN2WGQR89Lznwv5zwQ-gNkBrKvDvUwKSoKFBRQ9fxeukJp4zVxydoc5Geog1hRFaCCniOXuR8IAQYSHGFrlrgLQW-Qfpu77APw3jvgnE4DnjngnUJ62BxdkecF5eit3gf0xSDyzgGvJTMPOo8adz7YH3YrcE5xTnpEMc4Yhd0WHycXMov0bNBj9m9Or_X6NeXm7vtt-r2x9fv20-3lRFEsko3XBoJ2na96GyjjdVkAAqCS8mMtg3rW04701PpOG9FCz1wcNQ1bUcoA3aNPpx65_t-cta4sCQ9qjn5SacHFbVX_yrB79Uu_lYFGG8ILwXvTwUmxZyTGy5ZIGrlrg6rV6gVrlq5qzN3dSzh139fv0TPoIv-9qzrbPQ4FFDG54uNdbRA6Irt48n2x4_u4T8-oD5vf64bewQwp6Go</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Walle, UK ; Fagan, TC ; Topmiller, MJ ; Conradi, EC ; Walle, T</creator><creatorcontrib>Walle, UK ; Fagan, TC ; Topmiller, MJ ; Conradi, EC ; Walle, T</creatorcontrib><description>1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P < 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P < 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P < 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P < 0.001).</description><identifier>ISSN: 0306-5251</identifier><identifier>EISSN: 1365-2125</identifier><identifier>DOI: 10.1111/j.1365-2125.1994.tb04233.x</identifier><identifier>PMID: 8148214</identifier><identifier>CODEN: BCPHBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Biological and medical sciences ; Catecholaminergic system ; Chromatography, High Pressure Liquid ; Drug Synergism ; Estradiol - blood ; Estradiol - pharmacology ; Ethinyl Estradiol - pharmacology ; Female ; Humans ; Male ; Medical sciences ; Menstrual Cycle ; Middle Aged ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Norethindrone - pharmacology ; Pharmacology. Drug treatments ; Propranolol - blood ; Propranolol - pharmacokinetics ; Sex Characteristics ; Stereoisomerism ; Testosterone - analogs & derivatives ; Testosterone - blood ; Testosterone - pharmacology</subject><ispartof>British journal of clinical pharmacology, 1994-01, Vol.37 (1), p.21-25</ispartof><rights>1994 The British Pharmacological Society</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</citedby><cites>FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,309,310,314,776,780,785,786,881,4035,4036,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3920639$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8148214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walle, UK</creatorcontrib><creatorcontrib>Fagan, TC</creatorcontrib><creatorcontrib>Topmiller, MJ</creatorcontrib><creatorcontrib>Conradi, EC</creatorcontrib><creatorcontrib>Walle, T</creatorcontrib><title>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</title><title>British journal of clinical pharmacology</title><addtitle>Br J Clin Pharmacol</addtitle><description>1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P < 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P < 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P < 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P < 0.001).</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Catecholaminergic system</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Drug Synergism</subject><subject>Estradiol - blood</subject><subject>Estradiol - pharmacology</subject><subject>Ethinyl Estradiol - pharmacology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Menstrual Cycle</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Norethindrone - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Propranolol - blood</subject><subject>Propranolol - pharmacokinetics</subject><subject>Sex Characteristics</subject><subject>Stereoisomerism</subject><subject>Testosterone - analogs & derivatives</subject><subject>Testosterone - blood</subject><subject>Testosterone - pharmacology</subject><issn>0306-5251</issn><issn>1365-2125</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkFuL1DAUx4Mo67j6EYQgvrbm5NbWB0WH9QIL-rA-hzRJZzK0SUm6OvvtN2WGQR89Lznwv5zwQ-gNkBrKvDvUwKSoKFBRQ9fxeukJp4zVxydoc5Geog1hRFaCCniOXuR8IAQYSHGFrlrgLQW-Qfpu77APw3jvgnE4DnjngnUJ62BxdkecF5eit3gf0xSDyzgGvJTMPOo8adz7YH3YrcE5xTnpEMc4Yhd0WHycXMov0bNBj9m9Or_X6NeXm7vtt-r2x9fv20-3lRFEsko3XBoJ2na96GyjjdVkAAqCS8mMtg3rW04701PpOG9FCz1wcNQ1bUcoA3aNPpx65_t-cta4sCQ9qjn5SacHFbVX_yrB79Uu_lYFGG8ILwXvTwUmxZyTGy5ZIGrlrg6rV6gVrlq5qzN3dSzh139fv0TPoIv-9qzrbPQ4FFDG54uNdbRA6Irt48n2x4_u4T8-oD5vf64bewQwp6Go</recordid><startdate>199401</startdate><enddate>199401</enddate><creator>Walle, UK</creator><creator>Fagan, TC</creator><creator>Topmiller, MJ</creator><creator>Conradi, EC</creator><creator>Walle, T</creator><general>Blackwell Publishing Ltd</general><general>Blackwell Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>199401</creationdate><title>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</title><author>Walle, UK ; Fagan, TC ; Topmiller, MJ ; Conradi, EC ; Walle, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5063-a746c61ad9b59d7acda0f12154663cad73b8429cb26e448581b141e2e78902313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Catecholaminergic system</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Drug Synergism</topic><topic>Estradiol - blood</topic><topic>Estradiol - pharmacology</topic><topic>Ethinyl Estradiol - pharmacology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Menstrual Cycle</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Norethindrone - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Propranolol - blood</topic><topic>Propranolol - pharmacokinetics</topic><topic>Sex Characteristics</topic><topic>Stereoisomerism</topic><topic>Testosterone - analogs & derivatives</topic><topic>Testosterone - blood</topic><topic>Testosterone - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walle, UK</creatorcontrib><creatorcontrib>Fagan, TC</creatorcontrib><creatorcontrib>Topmiller, MJ</creatorcontrib><creatorcontrib>Conradi, EC</creatorcontrib><creatorcontrib>Walle, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walle, UK</au><au>Fagan, TC</au><au>Topmiller, MJ</au><au>Conradi, EC</au><au>Walle, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers</atitle><jtitle>British journal of clinical pharmacology</jtitle><addtitle>Br J Clin Pharmacol</addtitle><date>1994-01</date><risdate>1994</risdate><volume>37</volume><issue>1</issue><spage>21</spage><epage>25</epage><pages>21-25</pages><issn>0306-5251</issn><eissn>1365-2125</eissn><coden>BCPHBM</coden><abstract>1. Plasma binding of tritium‐labelled racemic propranolol (P) was measured by equilibrium dialysis. The unbound enantiomers were separated by h.p.l.c. after chiral derivatization. The binding of (‐)‐P was higher than that of (+)‐P. 2. Contrary to previous suggestions, a sex difference in the plasma binding of the P enantiomers (9 young women, 12 young men) was not observed. The unbound percentage of (‐)‐P was 9.2 +/‐ 1.8 (mean +/‐ s.d.) in women vs 9.1 +/‐ 1.7 in men; for (+)‐ P it was 10.8 +/‐ 1.8 vs 10.8 +/‐ 2.1. 3. In the nine women, the binding did not change with fluctuating plasma oestradiol concentrations during the menstrual cycle. Testosterone cypionate doubled the circulating concentrations of testosterone in eight men but had no effect on P binding. 4. Ethinyl oestradiol (50 micrograms day‐1) alone or together with norethindrone (OCD) in eight of the women produced an increase in the unbound percentage of both (‐)‐P (11.4 +/‐ 2.6 vs 9.5 +/‐ 1.6 for control; P < 0.001) and (+)‐P (13.2 +/‐ 2.5 vs 11.2 +/‐ 1.5 for control; P < 0.001). This was due to a decrease in the plasma concentrations of alpha 1‐acid glycoprotein from 0.54 +/‐ 0.11 mg ml‐1 in control to 0.37 +/‐ 0.08 mg ml‐1 (P < 0.001) during ethinyl oestradiol treatment. 5. Enantioselectivity in the unbound fraction of P increased with increasing total binding from a (‐)/(+)‐ratio of 0.93 at 84% binding to a (‐)/(+)‐ratio of 0.78 at 94% binding (P < 0.001).</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>8148214</pmid><doi>10.1111/j.1365-2125.1994.tb04233.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0306-5251 |
ispartof | British journal of clinical pharmacology, 1994-01, Vol.37 (1), p.21-25 |
issn | 0306-5251 1365-2125 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1364704 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Adult Biological and medical sciences Catecholaminergic system Chromatography, High Pressure Liquid Drug Synergism Estradiol - blood Estradiol - pharmacology Ethinyl Estradiol - pharmacology Female Humans Male Medical sciences Menstrual Cycle Middle Aged Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Norethindrone - pharmacology Pharmacology. Drug treatments Propranolol - blood Propranolol - pharmacokinetics Sex Characteristics Stereoisomerism Testosterone - analogs & derivatives Testosterone - blood Testosterone - pharmacology |
title | The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T04%3A15%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20influence%20of%20gender%20and%20sex%20steroid%20hormones%20on%20the%20plasma%20binding%20of%20propranolol%20enantiomers&rft.jtitle=British%20journal%20of%20clinical%20pharmacology&rft.au=Walle,%20UK&rft.date=1994-01&rft.volume=37&rft.issue=1&rft.spage=21&rft.epage=25&rft.pages=21-25&rft.issn=0306-5251&rft.eissn=1365-2125&rft.coden=BCPHBM&rft_id=info:doi/10.1111/j.1365-2125.1994.tb04233.x&rft_dat=%3Cwiley_pubme%3EBCP4233%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8148214&rfr_iscdi=true |